Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-12-06
1986-02-18
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514929, A61K 31415
Patent
active
045714037
ABSTRACT:
The anginal medicated compound according to the present invention comprises the active principle 2,4,6,8-tetramethyl-2,4,6,8-tetraazobicyclo-/3,3,0/-octanedione-3,7 of the formula: ##STR1## in combination with a pharmaceutical carrier. The medicated compound according to the present invention is useful for the treatment of patients suffering from ischemic heart disease.
REFERENCES:
Chem. Abstr. 97: 104,040g, 1982.
Chem. Abstr. 98: 83,542a, 1983.
Kaverina et al., Cardiology, Monthly Jour. Med. Moscow, vol. XV, No. 7, O 1961.
Kaverina et al., Cardiology, Monthly Jour. Med. Moscow, vol. XI, No. 11.
Bogoyavlensky Vladimir F.
Darinsky Nikolai V.
Epishina Lia V.
Kamburg Roman A.
Karpov Anatoly M.
Institut Organicheskoi Khimii Imeni N.D. Zelinskogo Akademii Nau
Meyers Albert T.
Rollins Jr. John W.
LandOfFree
Antianginal medicated compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antianginal medicated compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antianginal medicated compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1551045